Psychiatrist

Nathan Rosecrans, MD

855 Silver Ave Sw, Albuquerque, New Mexico, 87102-3020

About Nathan Rosecrans

Nathan Rosecrans is a psychiatrist based in Albuquerque, New Mexico who is specialized in Psychiatry. Active license number of Nathan Rosecrans is MD2024-1072 for Psychiatry in New Mexico. His current practice location is 855 Silver Ave Sw, Albuquerque. Patients can contact him at 505-532-9828. Nathan Rosecrans, MD, specializes in Psychiatry and his NPI number (Unique professional ID assigned by NPPES) is 1427453380.

Nathan Rosecrans specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.

Practice Information

Nathan Rosecrans's specialty, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.

Provider Name Nathan Rosecrans
Specialization Psychiatry
Credentials MD
Gender Male
Practice Address: 855 Silver Ave Sw,
Albuquerque, NM - 87102-3020

Professional Identification Codes

NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to healthcare providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.

NPI Number1427453380
NPI Enumeration Date: 04 Nov, 2014
NPI Last Update On: 14 Jul, 2026

Medical Licenses:

Healthcare professionals can hold one or more medical licenses for different specialties in the same state or different states. Related medical licenses for Nathan Rosecrans are as mentioned below.

License NumberSpecializationStateStatus
MD2024-1072Psychiatry New MexicoPrimary

Mailing Address

Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned Practice address.

Nathan Rosecrans
855 Silver Ave Sw,
Albuquerque, NM - 87102-3020
Phone: 505-532-9828

Book an Appointment with Nathan Rosecrans

To schedule an appointment, contact Nathan Rosecrans at 855 Silver Ave Sw, Albuquerque, New Mexico or call the phone number listed below.

Book an Appointment

Frequently Asked Questions

Below are some commonly asked questions about Nathan Rosecrans:

Nathan Rosecrans is a psychiatrist specializing in Psychiatry. He specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.

Yes, Nathan Rosecrans is currently accepting new patients. To schedule an appointment, contact the office directly and schedule an appointment.
*Availability may change. Please contact the office directly to ask about appointments.

Nathan Rosecrans practices at 855 Silver Ave Sw, Albuquerque, New Mexico, 87102-3020.

To schedule an appointment with Nathan Rosecrans, please contact the office at 505-532-9828.

Reviews & Feedback

Have you visited Nathan Rosecrans? Share your experience to help others looking for a psychiatrist in Albuquerque, NM.

Read Reviews / Give Feedback
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 September, 2026.